PDL BioPharma, Inc. Shareholders' Equity
PDL BioPharma, Inc. had Shareholders' Equity of $425.21 million as of 2020-08-31, per its 10-Q filed 2020-11-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2021-03-29
- 2020-08-31: Stockholders' Equity Attributable to Parent $425.21M.
- 2020-06-30: Stockholders' Equity Attributable to Parent $420.47M.
- 2020-03-31: Stockholders' Equity Attributable to Parent $553.23M.
- 2019-12-31: Stockholders' Equity Attributable to Parent $593.20M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2020-08-31 | $425.21M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $420.47M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $553.23M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $593.20M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $637.42M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $665.23M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $693.78M 10-Q · filed 2020-11-13 | $693.27M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $729.78M 10-Q · filed 2020-11-13 | |
| 2018-09-30 | $739.39M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $712.63M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $843.11M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $845.89M 10-Q · filed 2019-11-06 | |
| 2017-09-30 | $822.98M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $818.80M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $758.70M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $751.14M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $749.63M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $738.65M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $742.53M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $695.95M 10-K · filed 2019-03-15 | |
| 2015-09-30 | $595.96M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $527.21M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $451.94M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $460.44M 10-K · filed 2018-03-16 | |
| 2014-09-30 | $402.01M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $296.66M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $202.21M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $113.49M 10-K · filed 2017-03-01 | |
| 2013-09-30 | $52.89M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$1.26M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$93.67M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$68.12M 10-K · filed 2016-02-23 | |
| 2012-09-30 | -$115.48M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | -$161.11M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | -$243.78M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | -$204.27M 10-K · filed 2015-02-23 | |
| 2011-09-30 | -$243.24M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | -$293.51M 10-Q · filed 2011-07-29 | |
| 2011-03-31 | -$371.20M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | -$324.18M 10-K · filed 2014-03-03 | |
| 2010-09-30 | -$304.54M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | -$434.86M 10-Q · filed 2010-07-29 | |
| 2009-12-31 | -$415.95M 10-K · filed 2013-03-01 | |
| 2008-12-31 | -$352.57M 10-K · filed 2012-02-23 | |
| 2007-12-31 | $507.61M 10-K · filed 2011-03-01 |